NovaBridge Biosciences (NBP) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesGeneral And Administrative Expenses
0375K750K1M2M2M2M3M3MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

EBITDA

EBITDA
-2M-2M-1M-1M-1000K-750K-500K-250K1Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

EPS

Revenue Variation (%)

Income Variation (%)

Operating Income Variation
0612192531384450Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-200-175-150-125-100-74-49-241Q3 2024Q4 2024

Income YoY Variation (%)

Price-to-Earning Ratio

P/E Ratio
-20-17-15-12-10-7-4-21Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0100K200K300K400K500K600K700K800KQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Per Share Metrics

Net Income Per ShareOperating Cash Flow Per Share
000001111Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
0625K1M2M2M3M4M4M5MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Free Cash Flow

Cash At End Of Period
038M75M112M150M188M225M262M300MQ3 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
010M20M30M40M50M60M70M80MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025
🏦 Balance Sheet
📈 Key Metrics